Reviews and feature articleSmall-airways dysfunction associates with respiratory symptoms and clinical features of asthma: A systematic review
Section snippets
Asthma symptoms and control
Several studies have investigated the association between asthma symptoms or control and small-airways dysfunction, as reflected by different parameters of the small airways. Symptoms were assessed with asthma questionnaires or self-reported by the patient.
Takeda et al15 measured large- and small-airways function with impulse oscillometry in 65 patients with stable asthma and assessed associations with health status, dyspnea, and asthma control using the St George's Respiratory Questionnaire,
Occurrence of an asthma exacerbation
Bourdin et al21 showed that frequent (≥2/y) exacerbators have a higher degree of small-airways dysfunction as reflected by the SBNT phase III slope than infrequent exacerbators (<2/y), whereas FEV1 percent predicted values were comparable between these 2 groups (Fig 2, B). These findings are in line with those of in't Veen et al,33 who demonstrated that frequent exacerbators have a higher SBNT closing volume and closing capacity than infrequent exacerbators.
Air trapping can be assessed by using
Nocturnal asthma
We identified several studies investigating the association between small-airways dysfunction and nocturnal asthma. First, Kraft et al39 showed that peripheral airways resistance, as measured with a wedged bronchoscope, is increased in patients with nocturnal compared with nonnocturnal asthma. A further study investigated both endobronchial and transbronchial biopsy specimens at daytime (4 am) and nighttime (4 pm) in 11 patients with nocturnal asthma, which was defined as a 15% or greater
Change of small-airways function during a provocation test
Two studies have used the wedged bronchoscope technique to investigate the response of the small airways to a provocation test.45, 46 In one study peripheral airways resistance increased faster in patients with asthma than in healthy control subjects after local application of histamine.45 The other study demonstrated that greater peripheral airways resistance is associated with more BHR to methacholine.46 Together, these results confirm the sensitivity of the small airways to nonallergic
Involvement of the small airways in the response to exercise
Fonseca-Guedes et al61 found a significant correlation between the exercise-induced decrease in FEF25%-75% and FEV1, particularly in patients with moderate-to-severe asthma. Interestingly, in patients with mild asthma, a significant decrease in FEF25%-75% (≥26%) was observed, whereas FEV1 did not decrease by more than 10%. In addition, Rundell et al62 analyzed lung function and asthma symptoms in ice hockey players before and after exercise and observed a significantly lower baseline FEF25%-75%
Effects of allergen exposure on small-airways dysfunction
Asthma and allergies are strongly associated, and allergen exposure can provoke asthma symptoms in sensitized subjects. Allergen exposure can result in an immediate airways response, the so-called early asthmatic response, followed by a late-phase response in a subset of asthmatic patients.74
The role of the small airways in the allergic response has been investigated by the change in the FEF50% after breathing a mixture of helium-oxygen compared with room air.75, 76 Because of the lower gas
Association of small-airways dysfunction and exposure to particulate air pollution
Both in children and adults with asthma, higher levels of particulate air pollution have been associated with an increase in respiratory symptoms and use of rescue medication and a decrease in lung function.90, 91, 92, 93, 94 Particulate air pollution can be categorized according to particle size. Particulate matter larger than 10 μm in diameter (PM10) reflects the coarse particle fraction that will mainly deposit in the larger airways, particulate matter of less than 2.5 μm in diameter (PM2.5)
Effect of asthma treatment on small-airways function and symptoms
Several studies have investigated the effect of treatment targeting the small airways on asthma control. In a recent study Farah et al106 investigated the predictive value of the change in asthma control after either ICS uptitration in patients with poorly controlled asthma (ACQ >1.5) or those with steroid-naive asthma or ICS downtitration in the case of patients with well-controlled asthma. A higher level of small-airways dysfunction, as reflected by higher Sacin and Scond values, was the only
Conclusions
This systematic review demonstrates that small-airways dysfunction is associated with clinical features of asthma: worse control of asthma,15, 16, 20, 21 higher numbers of exacerbations,21, 27, 33 nocturnal asthma,40, 41, 44 more severe BHR,55, 56, 59, 60 exercise-induced asthma,61, 64, 67, 68, 69, 70, 71 and the late-phase allergic response (Table II).∗
References (120)
- et al.
Small airway disease in asthma and COPD: clinical implications
Chest
(2011) Therapeutic significance of distal airway inflammation in asthma
J Allergy Clin Immunol
(2002)- et al.
Inflammation of small airways in asthma
J Allergy Clin Immunol
(1997) - et al.
Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide
J Allergy Clin Immunol
(2005) - et al.
Relating small airways to asthma control by using impulse oscillometry in children
J Allergy Clin Immunol
(2012) - et al.
The role of the small airways in the clinical expression of asthma in adults
J Allergy Clin Immunol
(2012) - et al.
Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma
Chest
(2004) - et al.
Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity
Chest
(2007) - et al.
Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma
Chest
(1992) - et al.
Gas trapping is associated with severe exacerbation in asthmatic children
Respir Med
(2010)
A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis
Chest
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics
Chest
Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing
J Allergy Clin Immunol
Methacholine-induced asthma symptoms correlate with impulse oscillometry but not spirometry
Respir Med
Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception
Chest
Overall contribution of chest wall hyperinflation to breathlessness in asthma
Chest
Determinants of airway hyperresponsiveness in mild asthma
Ann Allergy Asthma Immunol
Small airway function, exhaled NO and airway hyper-responsiveness in paediatric asthma
Respir Med
Site of airflow obstruction during early and late phase asthmatic responses to allergen bronchoprovocation
Chest
Small airways response to naturalistic cat allergen exposure in subjects with asthma
J Allergy Clin Immunol
Airborne allergens associated with asthma: particle sizes carrying dust mite and rat allergens measured with a cascade impactor
J Allergy Clin Immunol
Subpollen particles: carriers of allergenic proteins and oxidases
J Allergy Clin Immunol
Effect of particulate air pollution on lung function in adult and pediatric subjects in a Seattle panel study
Chest
Site and nature of airway obstruction in chronic obstructive lung disease
N Engl J Med
Resistance of central and peripheral airways measured by a retrograde catheter
J Appl Physiol
Stress distribution in lungs: a model of pulmonary elasticity
J Appl Physiol
The lung's “quiet zone.”
N Engl J Med
Morphometry of the human lung
The small airways and distal lung compartment in asthma and COPD: a time for reappraisal
Allergy
The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1?
Allergy
The distal airways: are they important in asthma?
Eur Respir J
The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics
Eur Respir J
Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma
Am J Respir Crit Care Med
Relationship between small airway function and health status, dyspnea and disease control in asthma
Respiration
Relationship between frequency dependence of lung compliance and distribution of ventilation
J Clin Invest
Convection- and diffusion-dependent ventilation maldistribution in normal subjects
J Appl Physiol
Nonreversible conductive airway ventilation heterogeneity in mild asthma
J Appl Physiol
Nitrogen washout slope in poorly controlled asthma
Allergy
Peripheral inflammation in patients with asthmatic symptoms but normal lung function
J Asthma
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma
Am J Respir Crit Care Med
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Eur Respir J
Clinical patterns in asthma based on proximal and distal airway nitric oxide categories
Respir Res
Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity
Allergy
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma
Eur Respir J
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Eur Respir J
Heterogeneity of bronchial asthma. Sub-populations—or different stages of the disease
Allergy
Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes
Am J Respir Crit Care Med
Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy
J Breath Res
Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma
Thorax
Distal lung dysfunction at night in nocturnal asthma
Am J Respir Crit Care Med
Cited by (0)
Supported by Chiesi.
Disclosure of potential conflict of interest: D. S. Postma has received grants from the Dutch Asthma Foundation, NWO, ZonMw, SAB, AstraZeneca, and Chiesi and has received travel support from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Nycomed/Takeda. M. van den Berge has consulted for GlaxoSmithKline and Novartis and has received payment for a lecture for Nycomed. The rest of the authors declare that they have no relevant conflicts of interest.